| Ident. | Authors (with country if any) | Title |
|---|
| 000684 (2017) |
Tulio De Oliveira ; Ayesha B M. Kharsany ; Tiago Gr F ; Cherie Cawood ; David Khanyile ; Anneke Grobler ; Adrian Puren ; Savathree Madurai ; Cheryl Baxter ; Quarraisha Abdool Karim ; Salim S Abdool Karim | Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. |
| 000732 (2017) |
Krista L. Dong ; Amber Moodley ; Douglas S. Kwon ; Musie S. Ghebremichael ; Mary Dong ; Nasreen Ismail ; Zaza M. Ndhlovu ; Jenniffer M. Mabuka ; Daniel M. Muema ; Karyn Pretorius ; Nina Lin ; Bruce D. Walker ; Thumbi Ndung'U | Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study. |
| 000812 (2017) |
Anneke Grobler ; Cherie Cawood ; David Khanyile ; Adrian Puren ; Ayesha B M. Kharsany | Progress of UNAIDS 90-90-90 targets in a district in KwaZulu-Natal, South Africa, with high HIV burden, in the HIPSS study: a household-based complex multilevel community survey. |
| 000902 (2017) |
Tamsen J. Rochat ; Alan Stein ; Mario Cortina-Borja ; Frank Tanser ; Ruth M. Bland | The Amagugu intervention for disclosure of maternal HIV to uninfected primary school-aged children in South Africa: a randomised controlled trial. |
| 000905 (2017) |
Noah Haber ; Frank Tanser ; Jacob Bor ; Kevindra Naidu ; Tinofa Mutevedzi ; Kobus Herbst ; Kholoud Porter ; Deenan Pillay ; Till B Rnighausen | From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa. |
| 000916 (2017) |
Vivek Jain ; Maya L. Petersen ; Teri Liegler ; Dathan M. Byonanebye ; Dalsone Kwarisiima ; Gabriel Chamie ; Norton Sang ; Doug Black ; Tamara D. Clark ; Andras Ladai ; Albert Plenty ; Jane Kabami ; Emmanuel Ssemmondo ; Elizabeth A. Bukusi ; Craig R. Cohen ; Edwin D. Charlebois ; Moses R. Kamya ; Diane V. Havlir | Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. |
| 000986 (2017) |
Andrea L. Wirtz ; Gift Trapence ; Dunker Kamba ; Victor Gama ; Rodney Chalera ; Vincent Jumbe ; Rosemary Kumwenda ; Marriam Mangochi ; Stephane Helleringer ; Chris Beyrer ; Stefan Baral | Geographical disparities in HIV prevalence and care among men who have sex with men in Malawi: results from a multisite cross-sectional survey. |
| 000A71 (2017) |
Ellen C. Caniglia ; Lauren E. Cain ; Caroline A. Sabin ; James M. Robins ; Roger Logan ; Sophie Abgrall ; Michael J. Mugavero ; Sonia Hernández-Díaz ; Laurence Meyer ; Remonie Seng ; Daniel R. Drozd ; George R. Seage ; Fabrice Bonnet ; Francois Dabis ; Richard D. Moore ; Peter Reiss ; Ard Van Sighem ; William C. Mathews ; Julia Del Amo ; Santiago Moreno ; Steven G. Deeks ; Roberto Muga ; Stephen L. Boswell ; Elena Ferrer ; Joseph J. Eron ; Sonia Napravnik ; Sophie Jose ; Andrew Phillips ; Amy C. Justice ; Janet P. Tate ; John Gill ; Antonio Pacheco ; Valdilea G. Veloso ; Heiner C. Bucher ; Matthias Egger ; Hansjakob Furrer ; Kholoud Porter ; Giota Touloumi ; Heidi Crane ; Jose M. Miro ; Jonathan A. Sterne ; Dominique Costagliola ; Michael Saag ; Miguel A. Hernán | Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. |
| 000A97 (2017) |
Mark A. Boyd ; Janaki Amin ; Patrick W G. Mallon ; Nagalingeswaran Kumarasamy ; Johan Lombaard ; Robin Wood ; Ploenchan Chetchotisakd ; Praphan Phanuphak ; Lerato Mohapi ; Iskandar Azwa ; Waldo H. Belloso ; Jean-Michel Molina ; Jennifer Hoy ; Cecilia L. Moore ; Sean Emery ; David A. Cooper | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. |
| 000B80 (2017) |
Jemma O'Connor ; Michael J. Vjecha ; Andrew N. Phillips ; Brian Angus ; David Cooper ; Beatriz Grinsztejn ; Gustavo Lopardo ; Satyajit Das ; Robin Wood ; Aimee Wilkin ; Hartwig Klinker ; Pacharee Kantipong ; Karin L. Klingman ; David Jilich ; Elbushra Herieka ; Eileen Denning ; Ibrahim Abubakar ; Fred Gordin ; Jens D. Lundgren | Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. |
| 000C96 (2017) |
Catherine Orrell ; Debbie P. Hagins ; Elena Belonosova ; Norma Porteiro ; Sharon Walmsley ; Vicenç Falc ; Choy Y. Man ; Alicia Aylott ; Ann M. Buchanan ; Brian Wynne ; Cindy Vavro ; Michael Aboud ; Kimberly Y. Smith | Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study. |
| 000D35 (2017) |
Pedro Cahn ; Richard Kaplan ; Paul E. Sax ; Kathleen Squires ; Jean-Michel Molina ; Anchalee Avihingsanon ; Winai Ratanasuwan ; Evelyn Rojas ; Mohammed Rassool ; Mark Bloch ; Linos Vandekerckhove ; Peter Ruane ; Yazdan Yazdanpanah ; Christine Katlama ; Xia Xu ; Anthony Rodgers ; Lilly East ; Larissa Wenning ; Sandy Rawlins ; Brenda Homony ; Peter Sklar ; Bach-Yen Nguyen ; Randi Leavitt ; Hedy Teppler | Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. |
| 000E14 (2017) |
Ide Cremin ; Lyle Mckinnon ; Joshua Kimani ; Peter Cherutich ; Gloria Gakii ; Festus Muriuki ; Katharine Kripke ; Robert Hecht ; Michael Kiragu ; Jennifer Smith ; Wes Hinsley ; Lawrence Gelmon ; Timothy B. Hallett | PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study. |
| 000E69 (2017) |
Salim S Abdool Karim | Assessing progress with HIV incidence in national cohorts. |
| 000E95 (2017) |
Olalekan A. Uthman ; Jean B. Nachega ; Jean Anderson ; Steve Kanters ; Edward J. Mills ; Françoise Renaud ; Shaffiq Essajee ; Meg C. Doherty ; Lynne M. Mofenson | Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis. |
| 000E96 (2017) |
Linda-Gail Bekker ; Surita Roux ; Elaine Sebastien ; Ntando Yola ; K Rivet Amico ; James P. Hughes ; Mark A. Marzinke ; Craig W. Hendrix ; Peter L. Anderson ; Vanessa Elharrar ; Michael Stirratt ; James F. Rooney ; Estelle Piwowar-Manning ; Susan H. Eshleman ; Laura Mckinstry ; Maoji Li ; Bonnie J. Dye ; Robert M. Grant | Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. |
| 000F58 (2017) |
Jean B. Nachega ; Edward J. Mills ; Olalekan A. Uthman ; Francoise Renaud ; Lynne M. Mofenson | Preconception ART and preterm birth: real effect or selection bias? - Authors' reply. |
| 001809 (2017) |
Tulio De Oliveira ; Ayesha B M. Kharsany ; Tiago Gr F ; Cherie Cawood ; David Khanyile ; Anneke Grobler ; Adrian Puren ; Savathree Madurai ; Cheryl Baxter ; Quarraisha Abdool Karim ; Salim S Abdool Karim | Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. |
| 001834 (2017) |
Krista L. Dong ; Amber Moodley ; Douglas S. Kwon ; Musie S. Ghebremichael ; Mary Dong ; Nasreen Ismail ; Zaza M. Ndhlovu ; Jenniffer M. Mabuka ; Daniel M. Muema ; Karyn Pretorius ; Nina Lin ; Bruce D. Walker ; Thumbi Ndung'U | Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study. |
